What is the treatment for Influenza B in patients with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Treatment for Influenza B in Patients with End-Stage Renal Disease (ESRD)

  • The provided studies do not specifically address the treatment for Influenza B in patients with ESRD. However, they discuss the importance of vaccination and management of influenza in general for patients with ESRD.
  • According to 1, proper management of patients with ESRD includes vaccination, monitoring for symptoms, isolation of potentially infected patients, and appropriate antiviral therapies.
  • The studies emphasize the importance of vaccination against influenza for patients with ESRD, despite the suggested inferior efficacy among these patients 2, 3, 4.
  • In terms of antiviral therapies, 1 mentions that they are part of the proper management of patients with ESRD, but does not provide specific details on the treatment for Influenza B.
  • It is essential to note that the available evidence on the protective effects of influenza vaccination in patients with ESRD is limited and of very low quality 4.

Vaccination and Prevention

  • Vaccination against seasonal influenza is recommended for patients with ESRD 5, 2, 3, 4.
  • The studies highlight the importance of vaccination in preventing influenza-related complications and reducing mortality in patients with ESRD 2, 3, 4.
  • According to 3, vaccination was associated with a significantly reduced risk of influenza infection and mortality in patients with ESRD.

Management and Outcomes

  • Patients with ESRD are more susceptible to serious morbidity and mortality associated with influenza infection 1.
  • Proper management of patients with ESRD, including vaccination, monitoring, and antiviral therapies, can improve outcomes and reduce the risk of complications 1.
  • The studies emphasize the need for further research to determine the effectiveness of influenza vaccination in patients with ESRD and to improve the quality of evidence 4.

References

Research

Influenza vaccination in patients with end-stage renal disease.

Expert opinion on drug safety, 2015

Research

Outbreak of Influenza A(H1N1) in a Kidney Transplant Unit-Protective Effect of Vaccination.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015

Research

End-Stage Renal Disease: Medical Management.

American family physician, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.